Zum Hauptinhalt springen
Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Direct-Acting Antivirals against Hepatitis C -

Direct-Acting Antivirals against Hepatitis C

Current Issues and Future Perspectives
Buch | Softcover
300 Seiten
2026
Academic Press Inc (Verlag)
978-0-443-41363-6 (ISBN)
CHF 239,95 inkl. MwSt
  • Noch nicht erschienen (ca. Mai 2026)
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken
Direct-Acting Antivirals against Hepatitis C: Current Issues and Future Perspectives is a comprehensive reference that explores Chronic Hepatitis C management. This authoritative reference covers the mechanisms, efficacy, and future potential of Direct-Acting Antivirals (DAAs), offering valuable insights for clinicians, researchers, and students in hepatology and infectious diseases. Structured into three sections, this reference covers a wide range of topics related to DAAs in the management of Hepatitis C. In Section 1, readers will gain a thorough understanding of HCV infection, its clinical significance, and the immune response involved. They will also explore the molecular mechanisms of DAAs and the different classes available. Section 2 focuses on the practical aspects of using DAAs in the treatment of HCV. Readers will discover the clinical efficacy of different DAA regimens, the safety and tolerability considerations, and the additional benefits of DAA treatment beyond virological response. The section also covers current treatment guidelines and individualized approaches for specific patient populations. In Section 3, readers will learn the challenges and future directions in DAA therapy including antiviral resistance in HCV and strategies for managing and overcoming resistance. The book also explores the relationship between DAA therapy and hepatocellular carcinoma, as well as the current limitations and unmet needs in DAA therapy.

Direct-Acting Antivirals against Hepatitis C: Current Issues and Future Perspectives is a comprehensive and indispensable resource for anyone involved in the management of Chronic Hepatitis C. With its in-depth exploration of DAAs, from their molecular mechanisms to their clinical applications and future directions, this book equips clinicians, researchers, and students with the knowledge and insights needed to enhance their practices and contribute to the global fight against HCV infection.

Mohamed El-Kassas, a distinguished figure in hepatology, held prestigious positions in global medical organizations such as IASL, AHPBCC, WGO, Global NASH Council, and SLMENA. He has also held administrative roles in EARTH and the Egyptian National Committee for the Control of Viral Hepatitis. With a PG Diploma in Clinical Research, he received awards and recognition for his research, including the Best Arab Researcher Prize in Natural Sciences. He has published over 200 peer-reviewed manuscripts and served on the editorial boards of journals like PLOS One, Frontiers, and JCTH. He also reviewed for over 70 international journals, contributing to the field of hepatology.

Section 1. Direct-Acting Antivirals (DAAs) in Hepatitis C
1. Hepatitis C Virus Overview
2. HCV-Host Interactions: Virus specific factors, virus host related determinants, and Intracellular Signaling
3. Introduction to Direct-Acting Antivirals: Mechanisms of Action and different classes

Section 2. Therapeutic Strategies and Clinical Applications of DAAs in managing HCV
4. Clinical Efficacy of different DAAs regimens
5. Safety and tolerability of different DAAs regimens
6. Benefits of treating HCV by DAAs beyond virological response
7. Current landscape and guidelines of DAAs treatment in general population
8. Individualized treatment approaches in various special patient populations

Section 3. Challenges and Future Directions in DAA Therapy
9. Antiviral Resistance in Hepatitis C and DAA Therapy
10. DAA Therapy and hepatocellular carcinoma
11. Limitations and unmet needs in DAAs therapy
12. Emerging Therapeutic Strategies and Future Directions
13. Access to DAAs therapy, and role of DAAs in targeted HCV elimination

Erscheint lt. Verlag 1.5.2026
Verlagsort San Diego
Sprache englisch
Maße 191 x 235 mm
Gewicht 450 g
Themenwelt Naturwissenschaften Biologie
ISBN-10 0-443-41363-0 / 0443413630
ISBN-13 978-0-443-41363-6 / 9780443413636
Zustand Neuware
Informationen gemäß Produktsicherheitsverordnung (GPSR)
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
Ein aktueller Blick auf das Mosaik der Menschwerdung

von Bastian Suhr; Dierk Suhr

Buch | Hardcover (2025)
Springer (Verlag)
CHF 69,95

von David Sadava; Jürgen Markl; David M. Hillis …

Buch | Hardcover (2019)
Springer Spektrum (Verlag)
CHF 153,95